G
Giulio Gabbiani
Researcher at University of Geneva
Publications - 354
Citations - 49723
Giulio Gabbiani is an academic researcher from University of Geneva. The author has contributed to research in topics: Actin & Myofibroblast. The author has an hindex of 104, co-authored 346 publications receiving 47497 citations. Previous affiliations of Giulio Gabbiani include French Institute of Health and Medical Research & Carnegie Mellon University.
Papers
More filters
Journal ArticleDOI
Myofibroblasts and mechano-regulation of connective tissue remodelling
TL;DR: It is clear that the understanding of the myofibroblast — its origins, functions and molecular regulation — will have a profound influence on the future effectiveness not only of tissue engineering but also of regenerative medicine generally.
Journal ArticleDOI
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.
TL;DR: It is shown that the subcutaneous administration of transforming growth factor- beta 1 to rats results in the formation of a granulation tissue in which alpha-SM actin expressing myofibroblasts are particularly abundant, suggesting that TGF beta 1 plays an important role in my ofibroblast differentiation during wound healing and fibrocontractive diseases by regulating the expression of alpha- SM actin in these cells.
Journal ArticleDOI
The Myofibroblast: One Function, Multiple Origins
Boris Hinz,Sem H. Phan,Victor J. Thannickal,Andrea Galli,Marie-Luce Bochaton-Piallat,Giulio Gabbiani +5 more
TL;DR: A better knowledge of the molecular mechanisms conducive to the appearance of differentiated myofibroblasts in each pathological situation will be useful for the understanding of fibrosis development in different organs and the planning of strategies aiming at their prevention and therapy.
Journal ArticleDOI
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.
TL;DR: Double immunofluorescent studies carried out with anti-alpha sm-1 and anti- desmin antibodies in several organs revealed a heterogeneity of stromal cells.
Journal ArticleDOI
The myofibroblast in wound healing and fibrocontractive diseases.
TL;DR: The demonstration that fibroblastic cells acquire contractile features during the healing of an open wound, thus modulating into myofibroblasts, has open a new perspective in the understanding of mechanisms leading to wound closure and fibrocontractive diseases.